Roche still is chasing...Roche started an early collaboration with bicycle (February 2020):
“Bicycle will receive a $30 million upfront payment; upfront payment and potential discovery, development, regulatory and commercial milestones could total up to $1.7 billion”
I wonder on the back of successful oncology program how early and on what terms would other companies start a collaboration with THTX?
“Roche is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.
Partnering opportunities we are looking for:
- Novel modalities and enabling technologies to expand the druggable target space
- Targeted or intracellular delivery
- Artificial intelligence for drug discovery
- Genomic Medicine platforms”
Roche | Pharma partnering - Research technologies